Drug discovery platform yields optimized compound against SARS-CoV-2 and shows promise against other RNA-based viruses

In a quest to develop new antiviral drugs for COVID-19 and other diseases, a collaboration led by scientists at The Wertheim UF Scripps Institute has identified a potential new drug against the virus that causes COVID-19.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup